Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 6c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.73), $0.06 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Grok, OpenAI, Claude all down simultaneously - Downdetector
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook
• Robinhood (HOOD) December 170, February 150 and February 180 calls active, share price up 15%